Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Naringenin attenuates testicular damage, germ cell death and oxidative stress in streptozotocin induced diabetic rats: naringenin prevents diabetic rat testicular damage

Souvik Roy, Noorjaman Rahaman, Faiqa Ahmed, Satyajit Metya, Santanu Sannigrahi

. 2013 ; 11 (3) : 195-208.

Language English Country Czech Republic

The aim of this study was to investigate the protective effect of naringenin on oxidative stress, on proinflammatory cytokines like TGF-beta1, IL-1beta and on programmed cell death in the testicular damage resulting from streptozotocin (STZ) induced diabetes in rats. Diabetes was induced by a single intraperitoneal injection of STZ (50 mg/kg), and the rats were treated with naringenin (5 mg/kg and 10 mg/kg) administered once a day orally for 10 weeks, starting 3 days after the STZ injection. At the end of the study, all animals were sacrificed. Testis tissue and blood samples were collected for the assessment of sperm parameters, and for biochemical and histopathological analysis. Naringenin treatment significantly decreased the levels of elevated tissue TBARS (thio-barbituric acid) and increased the superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx) enzyme activities in the testis tissues. The naringenin-treated rats in the diabetic group showed an improved histological appearance, sperm parameters, and serum testosterone levels, along with a decrement of terminal dUTP nick end-labeling (TUNEL) detected program cell death and a reduced over expression of TGF-beta1, IL-1beta in Sertoli cells and Leydig cells. These results suggest that naringenin is a food supplement potentially beneficial in reducing testicular damage in diabetic rats by decreasing the oxidative stress related to programmed cell death.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13032963
003      
CZ-PrNML
005      
20131213104755.0
007      
ta
008      
131012s2013 xr ad f 000 0eng||
009      
AR
024    7_
$a 10.2478/v10136-012-0026-7 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Roy, Souvik $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
245    10
$a Naringenin attenuates testicular damage, germ cell death and oxidative stress in streptozotocin induced diabetic rats: naringenin prevents diabetic rat testicular damage / $c Souvik Roy, Noorjaman Rahaman, Faiqa Ahmed, Satyajit Metya, Santanu Sannigrahi
504    __
$a Literatura
520    9_
$a The aim of this study was to investigate the protective effect of naringenin on oxidative stress, on proinflammatory cytokines like TGF-beta1, IL-1beta and on programmed cell death in the testicular damage resulting from streptozotocin (STZ) induced diabetes in rats. Diabetes was induced by a single intraperitoneal injection of STZ (50 mg/kg), and the rats were treated with naringenin (5 mg/kg and 10 mg/kg) administered once a day orally for 10 weeks, starting 3 days after the STZ injection. At the end of the study, all animals were sacrificed. Testis tissue and blood samples were collected for the assessment of sperm parameters, and for biochemical and histopathological analysis. Naringenin treatment significantly decreased the levels of elevated tissue TBARS (thio-barbituric acid) and increased the superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx) enzyme activities in the testis tissues. The naringenin-treated rats in the diabetic group showed an improved histological appearance, sperm parameters, and serum testosterone levels, along with a decrement of terminal dUTP nick end-labeling (TUNEL) detected program cell death and a reduced over expression of TGF-beta1, IL-1beta in Sertoli cells and Leydig cells. These results suggest that naringenin is a food supplement potentially beneficial in reducing testicular damage in diabetic rats by decreasing the oxidative stress related to programmed cell death.
650    _2
$a zvířata $7 D000818
650    _2
$a potkani Wistar $7 D017208
650    _2
$a mužské pohlaví $7 D008297
650    12
$a experimentální diabetes mellitus $x farmakoterapie $x krev $7 D003921
650    12
$a flavanony $x aplikace a dávkování $x farmakologie $7 D044950
650    _2
$a antagonisté estrogenu $x aplikace a dávkování $x farmakologie $7 D004965
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    12
$a testis $x enzymologie $x imunologie $x patologie $7 D013737
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a interleukin-1beta $7 D053583
650    _2
$a transformující růstový faktor beta1 $7 D053773
650    _2
$a testosteron $x krev $7 D013739
650    _2
$a počet spermií $x statistika a číselné údaje $7 D013076
650    _2
$a motilita spermií $x účinky léků $7 D013081
650    _2
$a statistika jako téma $7 D013223
650    _2
$a zárodečné buňky $x účinky léků $7 D005854
650    _2
$a imunohistochemie $7 D007150
650    _2
$a rastrovací tunelová mikroskopie $7 D016252
700    1_
$a Rahaman, Noorjaman $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
700    1_
$a Ahmed, Faiqa $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India $7 gn_A_00002462
700    1_
$a Metya, Satyajit $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
700    1_
$a Sannigrahi, Santanu $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 11, č. 3 (2013), s. 195-208 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2013/03/08.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y 4 $z 0
990    __
$a 20131012094746 $b ABA008
991    __
$a 20131213105440 $b ABA008
999    __
$a ok $b bmc $g 997136 $s 831415
BAS    __
$a 3
BMC    __
$a 2013 $b 11 $c 3 $d 195-208 $i 1214-021X $m Journal of Applied Biomedicine $n J. Appl. Biomed. (Čes. Budějovice Print) $x MED00012667
LZP    __
$c NLK188 $d 20131213 $a NLK 2013-43/ip

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...